⚕ GalenOps CRO console
← 714 (USA)

714-1288

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 714 (USA) (Dr. Clarke) · consented 2013-12-04
Adverse events
9
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

moderate assessed 2026-08-18

Moderate ARTHRALGIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-03-08 (study day 95.0); relationship: NONE

mild assessed 2026-08-18

Mild BACK PAIN — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-02-24 (study day 83.0); relationship: NONE

mild assessed 2026-08-18

Mild BACK PAIN — outcome: RECOVERED/RESOLVED; onset 2014-02-24 (study day 83.0); relationship: NONE

mild assessed 2026-08-18

Mild COUGH — outcome: RECOVERED/RESOLVED; onset 2014-01-22 (study day 50.0); relationship: NONE

mild assessed 2026-08-18

Mild DIARRHOEA — outcome: RECOVERED/RESOLVED; onset 2013-12-14 (study day 11.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild DIZZINESS — outcome: RECOVERED/RESOLVED; onset 2013-12-13 (study day 10.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-01-11 (study day 39.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild NASOPHARYNGITIS — outcome: RECOVERED/RESOLVED; onset 2014-01-22 (study day 50.0); relationship: NONE

moderate assessed 2026-08-18

Moderate SINUS BRADYCARDIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-05-27 (study day 175.0); relationship: REMOTE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.